Dexamethasone-induced hiccups in patients with COVID-19
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
International journal of clinical pharmacology and therapeutics - 61(2023), 8 vom: 08. Aug., Seite 371-373 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yagi, Tomomi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 26.07.2023 Date Revised 18.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5414/CP204429 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357906772 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357906772 | ||
| 003 | DE-627 | ||
| 005 | 20231226073611.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5414/CP204429 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1192.xml |
| 035 | |a (DE-627)NLM357906772 | ||
| 035 | |a (NLM)37288836 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yagi, Tomomi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dexamethasone-induced hiccups in patients with COVID-19 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.07.2023 | ||
| 500 | |a Date Revised 18.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Yasu, Takeo |e verfasserin |4 aut | |
| 700 | 1 | |a Tsubuku, Sumi |e verfasserin |4 aut | |
| 700 | 1 | |a Jinnai, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Otsuka, Kenta |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Shin |e verfasserin |4 aut | |
| 700 | 1 | |a Hagino, Takeshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical pharmacology and therapeutics |d 1997 |g 61(2023), 8 vom: 08. Aug., Seite 371-373 |w (DE-627)NLM075091739 |x 0946-1965 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2023 |g number:8 |g day:08 |g month:08 |g pages:371-373 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5414/CP204429 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2023 |e 8 |b 08 |c 08 |h 371-373 | ||